Skip to content

Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q1Scopus Q1
Citation
Web of Science 50Scopus 59
FWCI (Scopus)
2.57
JCR IF
JCR 2020 5.924
ISSN
1661-6596

Authors

  1. Jung Ho HanFirst authorPusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, South Korea
  2. Kim, MinJeongSungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea
  3. Kim, Hyeon JinColl Nat Sci, Dept Mol Biol, Busan 46241, South Korea
  4. Jang, Se BokColl Nat Sci, Dept Mol Biol, Busan 46241, South Korea
  5. Bae, Sung-JinPusan Natl Univ, Hlth Aging Korean Med Res Ctr, Yangsan 50612, South Korea
  6. Lee, In-KyuKyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu 41566, South Korea
  7. Ryu, DongryeolCorresponding authorSungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 16419, South Korea
  8. Ha, Ki-TaeCorresponding authorPusan Natl Univ, Sch Korean Med, Dept Korean Med Sci, Yangsan 50612, South Korea

Abstract

Resistance to anticancer therapeutics occurs in virtually every type of cancer and becomes a major difficulty in cancer treatment. Although 5-fluorouracil (5FU) is the first-line choice of anticancer therapy for gastric cancer, its effectiveness is limited owing to drug resistance. Recently, altered cancer metabolism, including the Warburg effect, a preference for glycolysis rather than oxidative phosphorylation for energy production, has been accepted as a pivotal mechanism regulating resistance to chemotherapy. Thus, we investigated the detailed mechanism and possible usefulness of antiglycolytic agents in ameliorating 5FU resistance using established gastric cancer cell lines, SNU620 and SNU620/5FU. SNU620/5FU, a gastric cancer cell harboring resistance to 5FU, showed much higher lactate production and expression of glycolysis-related enzymes, such as lactate dehydrogenase A (LDHA), than those of the parent SNU620 cells. To limit glycolysis, we examined catechin and its derivatives, which are known anti-inflammatory and anticancer natural products because epigallocatechin gallate has been previously reported as a suppressor of LDHA expression. Catechin, the simplest compound among them, had the highest inhibitory effect on lactate production and LDHA activity. In addition, the combination of 5FU and catechin showed additional cytotoxicity and induced reactive oxygen species (ROS)-mediated apoptosis in SNU620/5FU cells. Thus, based on these results, we suggest catechin as a candidate for the development of a novel adjuvant drug that reduces chemoresistance to 5FU by restricting LDHA.

Keywords

5-fluorouracilchemoresistantglycolysislactate dehydrogenasecatechinGREEN TEALDH-AOXIDATIVE STRESSTUMOR-GROWTHINHIBITIONRESISTANCEDRUGCHEMORESISTANCEGLYCOLYSISPHOSPHORYLATION

Identifiers

Scopus EID
2-s2.0-85106165668
WoS UID
000662012400001